Statement from the American Red Cross Regarding Changes at Holland LabAmerican Red Cross American Red Cross Biomedical Services continues to evaluate the ways in which we allocate our energy, staff and resources to achieve our priorities and maintain our fundamental businesses. After careful review and consideration, we have determined that we must refocus on our core mission of providing a safe and available blood supply. Accordingly, we have decided to reduce functions at the Jerome H. Holland Laboratory.  Specifically, the Red Cross will begin narrowing our R&D efforts to those activities that directly support blood products. This means we will no longer support externally funded research grants and programs or cellular therapies. We will continue to support research impacting blood banking. We are interested in exploring opportunities to transfer these high quality grant funded programs to another local organization which is active in biomedical research. Given our current strategic and financial imperatives, this decision is consistent with our mission. We appreciate all the fine work performed by the affected R&D staff over the last several years and realize this decision will have an impact on many of our staff members. We will make every effort to ensure this transition goes smoothly for all involved. Staff affected by this decision have been notified and will learn more about detailed actions in the coming weeks. This transition is expected to take place over the next several months and to be completed by June 2004. We will continue to consider prudent and necessary changes to Biomedical Services that will move us toward quality operations, regulatory compliance, and operational efficiency in our core business of blood services.
For more information, or to contact American Red Cross, see their website at: www.redcross.org |
 |
Email Article To A Friend |  |
Link to us! |
